MRNA Vaccines and Therapeutics Industry Share, Demand, and Future Forecast

MRNA Vaccines and Therapeutics Market Projected to Expand at 13% CAGR Through 2026

The “Global mRNA Vaccines and Therapeutics Market” is likely to grow at a CAGR of around 13% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth essentially attributes to the rising prevalence of infectious and chronic diseases, including HIV, diabetes, cancer, and cardiovascular diseases.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report -

https://www.marknteladvisors.com/query/request-sample/global-mrna-vaccines-and-therapeutics-market.html

Strategic Takeaways from the Report:

Market Sizing and Forecasting
Regulatory and Policy Influence
Competitive Trends and M&A Activity
Innovation Drivers and Disruptive Technologies
Investment Hotspots and Emerging Niches
Geographical Dynamics and Trade Flows

MRNA Vaccines and Therapeutics Market Segment Overview & Classification

This market is categorized to offer targeted insights across various operational and consumer-related verticals.

Segment List:

By mRNA Type

Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA

By Application Type

COVID mRNA Application
- Commercialised Vaccine
  - mRNA-1273
  - BNT162b2
- Pipeline Vaccines
  - CVnCoV
  - LUNAR-COV19
  - MRT5500
  - DS-5670
- Non-COVID mRNA Application
  - Immuno-Oncology
  - Cardiology
  - Endocrinology
  - Haematology
  - Other infectious & rare diseases

Based on Application Type, the market bifurcates into COVID mRNA Application and Non-COVID mRNA Application. Here, Non-COVID mRNA Application segments into Immuno-Oncology, Cardiology, Endocrinology, Haematology, and Other Infectious & Rare Diseases. Of them all, Infectious diseases accounted for more than 80% share in the Global mRNA Vaccines and Therapeutics Market. The mRNA Vaccine encodes the desired antigens from the mRNA sequence. When the mRNA vaccine gets injected, some information gets transferred to the cell to generate specific proteins in the cytoplasm. This protein initiates immune responses in the body and protects the body against diseases. Hence, the mRNA vaccine helps prevent transmission of various infectious diseases like HIV, Ebola, Influenza, and other Infectious Diseases, thereby likely to accelerate the segment growth in the forecast period, cites MarkNtel Advisors in their research report, “Global mRNA Vaccines and Therapeutics Market Analysis, 2021.”

By End Users

Hospitals & healthcare Clinics
Research Organisation & Institutions
Others

Based on End-Users, the market bifurcates into Hospitals & Healthcare Clinics, Research Organization & Institutions, and Others. Among these segments, Hospitals & healthcare Clinics acquired the largest share in the Global mRNA Vaccines and Therapeutics Market in the previous few years. The segment growth primarily owes to the rising patient footfall in hospitals and clinics. Additionally, an increasing number of patients suffering from respiratory diseases, cancer, and infectious diseases also leads to aiding the growth of Hospitals & Healthcare Clinics.

By Region

North America
South America
Europe
Asia-Pacific
Middle East & Africa.

Geographically, North America held the largest share in the Global mRNA Vaccines and Therapeutics Market in the past few years, owing to the abundant presence of prominent players & exponentially surging number of COVID-19 patients in the US. Additionally, mounting fund infusions, rising focus on precision medicines, favorable regulatory environment, and snowballing need to develop transformative therapeutics are other critical factors augmenting the market growth in North America.

These divisions help clarify demand patterns and expected shifts.

Market Driver

Increasing Cases of COVID-19 - mRNA vaccines help protect against various infectious diseases. The COVID-19 mRNA vaccines teach the cells to make a harmless piece of the spike protein. The spike protein lies on the surface of the COVID-19 virus. Once the mRNA vaccine gets injected, the body starts triggering an immune response, thereby creating antibodies against the virus. Moreover, mRNA vaccines are highly effective in combatting new variants of the COVID-19 virus. Hence, the increasing number of COVID-19 patients leads to accelerate the demand for mRNA vaccines and therapeutics.

MRNA Vaccines and Therapeutics Market Competitive Snapshot from 2021-2026

The report highlights established and emerging players in the global MRNA Vaccines and Therapeutics Market, evaluating their strengths, challenges, and potential for innovation.

Key Competitors Include:

Arcturus Therapeutics Holdings Inc.
BioNTech
CureVac N.V.
ethris GmbH
Gennova Biopharmaceuticals Ltd
GlaxoSmithKline plc
Moderna
Pantherna Therapeutics GmbH
Pfizer
Providence Therapeutics
Providence Therapeutics
Silence Therapeutics
Translate Bio
Versameb AG
Verve Therapeutics, Inc.

Their activities include partnerships, product launches, and geographic expansions.

MRNA Vaccines and Therapeutics Industry Prime Challenge

Transportation Challenges Associated with COVID-19 Vaccines - Transporting mRNA vaccines from the manufacturing site to vaccination centers is one of the biggest challenges for the logistic industry as these vaccines are time-sensitive and temperature-critical products. Therefore, issues while maintaining a cold supply chain to ensure its stability and lack of proper infrastructure to stockpile mRNA-based COVID-19 vaccines are the major factors restraining the market growth.

Frequently Asked Questions (FAQs):

What industries are most impacted by this market?
How is technology reshaping operations and offerings?
Which competitors dominate the landscape?
What risks could disrupt market expansion?
How should businesses respond to demand fluctuations?

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Read Blog:

Note: If you need additional information not included in the report, we can customize it to suit your requirements. https://www.marknteladvisors.com/query/request-sample/global-mrna-vaccines-and-therapeutics-market.html

Why Trust MarkNtel Advisors?

In-depth primary and secondary data validation
Focused on practical insights, not just raw numbers
Designed to support business strategy, not just reporting
Strong industry connections and real-time data flow
Transparent methodology and reliable sourcing

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India